Transpact Enterprises

BSE: 542765
Compare with peers
₹ 96.00▼ 4 (−4%)28 Oct, 02:49 pm IST
Market cap
₹ 4 Cr.
P/E
46.4x
P/B
7.21x
52-week range
81.47 – 234.9
ROE
16%
ROCE
13.9%
Dividend yield
0%
Debt / equity
0.11
Sector
Healthcare Equipment & Supplies
Industry
Medical Equipment & Supplies
Listed on
BSE

About

Transpact Enterprises Ltd is an India-based company, which is engaged in the primary business of dealing in shares, securities, commodities, currencies and their derivatives, stockbroker, share broker, sub-broker, authorized person, dealer, jobber, market maker, investment brokers, insurance broker, underwriter, and to carry out brokerage of all and every kind whatsoever, portfolio manager, investment advisors, mutual funds, wealth management and other related services or any other business in any other manner. Its core business is to carry on the business of consulting and advisory services on all aspects of corporate, financial and commercial matters including management consulting, debt structuring, debt advisory, project appraisals, or any related items or things, required by any person, corporate, firm or association of persons and to provide, execute and undertake related services in India or abroad.

Quick check

The five things to look at first. Open one for more.

Transpact Enterprises against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)46.4 against a typical 28.7: pricier than most peers (1st = cheapest).17th of 25
  • Share price, 3 months−30.8% against a typical −7.9%.22nd of 23
  • Size₹ 3.8 Cr. market value against a typical ₹ 238.1 Cr. (1st = largest).24th of 24

Share price

1Y change −57.2%
Volume (shares)Price (₹)
Close price

Financials

Standalone figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2020Mar 2021Sep 2021Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Sales000000000000
Expenses000000000000
Operating Profit−00−00−0−0−0−0−0000
OPM %—66.7%—6.7%—————75%70%55.6%
Other Income000000000000
Interest000000000000
Depreciation000000000000
Profit before tax−00−000−0−0−0−0000
Tax %0%50%0%—0%0%0%0%0%0%0%−33.3%
Net Profit−00−000−0−0−0−0000
EPS in Rs−2.070.26−6.4600.52−0.78−0.78−1.55−1.291.291.291.03

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
—
5 Years
43%
3 Years
−22%
TTM
125%
Compounded Profit Growth
10 Years
12%
5 Years
27%
3 Years
46%
TTM
700%
Stock Price CAGR
10 Years
—
5 Years
−11%
3 Years
−25%
TTM
—
Return on Equity
10 Years
−21%
5 Years
−11%
3 Years
0%
TTM
—

Shareholding

Latest: Mar 2026.

Promoters
16.16%
−2.07 pts in a year
Public
83.84%
+2.08 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 46.4xEPS (12 months) ₹ 2.07Median P/E 61.4x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Transpact Enterprises₹ 96.00₹ 4 Cr.46.4x7.2x16%—
Lenskart Solutions₹ 627.55₹ 1,08,959 Cr.228.9x13.6x—6.9%
Poly Medicure₹ 1,446.80₹ 14,582 Cr.53.9x5.7x—15.7%
Laxmi Dental₹ 171.25₹ 946 Cr.32.5x4.6x—10%
Hemant Surgical Industries₹ 570.00₹ 829 Cr.32.8x4.4x18.1%7.9%
Mallcom (India)₹ 905.00₹ 565 Cr.19x1.9x—5.1%

Management

Amrita Gupta
Company Secretary and Compliance Officer
Raman Talwar
Additional Executive Director

Prices are delayed and for information only. Nothing on this page is investment advice.